- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: rituximab [MabThera/Rituxan]
Total 3378 results
-
M.D. Anderson Cancer CenterCureTech LtdCompleted
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedNon-Hodgkin's Lymphoma (NHL)United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
French Innovative Leukemia OrganisationCompleted
-
Hospital Universitario Dr. Jose E. GonzalezCompletedImmune Thrombocytopenic PurpuraMexico
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieWithdrawnRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Seoul National University HospitalRoche Pharma AGUnknownEnd Stage Renal DiseaseKorea, Republic of
-
German CLL Study GroupRoche Pharma AG; Celgene; Mundipharma Research GmbH & Co KGCompletedChronic Lymphocytic LeukemiaGermany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
Claudio GobbiMerck AG SwitzerlandActive, not recruiting
-
Louisiana State University Health Sciences Center...Millennium Pharmaceuticals, Inc.WithdrawnFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaUnited States
-
E. Steve WoodleGlaxoSmithKlineCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterBiogenCompletedLymphoma, Mantle-CellUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingFollicular LymphomaUnited States
-
University of California, DavisCelgeneActive, not recruitingNon Hodgkin's LymphomaUnited States
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of ExcellenceTerminated
-
Weill Medical College of Cornell UniversityCelgeneCompletedChronic Lymphocytic LeukemiaUnited States
-
Institut CurieCentre Leon Berard; Institut Bergonié; Centre Hospitalier Universitaire, Amiens; Central Hospital, Nancy, France and other collaboratorsCompleted
-
Seagen Inc.Genentech, Inc.CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
St. Bortolo HospitalCompletedLymphoma, Mantle-CellItaly
-
Istituto Giannina GasliniCompleted
-
European Myeloma NetworkUniversitaire Ziekenhuizen KU Leuven; University of Roma La Sapienza; Hospital... and other collaboratorsCompletedWaldenstroms MacroglobulinemiaGreece
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
German CLL Study GroupAbbVie; Hoffmann-La Roche; Swiss Group for Clinical Cancer Research; Stichting... and other collaboratorsCompletedChronic Lymphocytic LeukemiaIreland, Germany, Israel, Austria, Belgium, Denmark, Switzerland, Finland, Sweden, Netherlands
-
National Institute of Allergy and Infectious Diseases...GlaxoSmithKline; PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network...Active, not recruitingNephrotic Syndrome | Membranous NephropathyUnited States, Canada
-
University of FloridaCompletedPompe DiseaseUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Richter Syndrome | Refractory Transformed Non-Hodgkin Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Kami Maddocks, MDPharmacyclics LLC.Active, not recruitingExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationCentre Henri BecquerelCompletedDiffuse Large B Cell LymphomaFrance, Belgium
-
Merck Sharp & Dohme LLCRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaPoland, Turkey, Denmark, Singapore, Hungary, Hong Kong, Chile, Malaysia, Brazil, Guatemala, China, Taiwan, South Africa, Colombia, United States, Ukraine, Australia, Mexico, Romania
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AbbVieRecruitingMantle Cell LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMantle Cell Lymphoma | Lymphocytic LeukemiaUnited States
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
Masonic Cancer Center, University of MinnesotaTerminated
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); BayerCompletedLymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
European Society for Blood and Marrow TransplantationEULARWithdrawnREFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSFrance
-
Asan Medical CenterUnknownPrecursor Cell Lymphoblastic Leukemia-LymphomaKorea, Republic of
-
Joseph TuscanoNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
David Rizzieri, MDGenzyme, a Sanofi Company; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Beth Israel Deaconess Medical CenterCompleted
-
University of WashingtonGenentech, Inc.CompletedDiabetic Nephropathies | Kidney Failure, Chronic | Glomerulonephritis, IGA | Hypertension, Renal
-
CelgeneActive, not recruitingNeoplasmsUnited States, France, Australia, Canada, Italy, Korea, Republic of, Spain, United Kingdom
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Italy, Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Poland, United States, United Kingdom, Turkey, Belgium, Thailand, Czechia